Peptic Ulcer Disease: 4 Questions Worth Asking Your Gastroenterologist

Why Asking the Right Questions Matters

A peptic ulcer is an open sore in the lining of the stomach or duodenum, the first part of the small intestine. An ulcer in the stomach is called a gastric ulcer; one in the duodenum is a duodenal ulcer. Although both fall under peptic ulcer disease, the appropriate evaluation and follow-up depend on the ulcer's location, likely cause, medication exposures, symptoms, and other findings.

It can be difficult to absorb those details during an appointment, particularly when you are uncomfortable or worried about a test result. You may leave with a prescription yet remain unsure why the ulcer developed, what each medicine is meant to do, or whether another test will be needed. Preparing a short list of questions can keep the conversation centered on decisions that affect your care.

The goal is not to arrive with a self-diagnosis or preferred prescription. It is to give your gastroenterologist an accurate history and understand the reasoning behind the plan. Bring a current medication list, including nonprescription pain relievers, and note any previous ulcer diagnoses, H. pylori treatment, endoscopy findings, allergies, or difficulty completing antibiotics. These details can materially affect the discussion.

The four questions below follow the path from cause to confirmation. They can also reveal what remains uncertain. A reasonable answer may be, “We need more information before deciding,” especially because digestive symptoms can overlap. That uncertainty is a reason to ask about the next step, not a reason to assume the worst.

This question shapes much of what follows. The National Institute of Diabetes and Digestive and Kidney Diseases identifies H. pylori infection and NSAID use as the most common causes of peptic ulcers. NSAIDs include aspirin, ibuprofen, and naproxen. When H. pylori is confirmed, treatment targets the infection. When an NSAID is involved, the clinician considers why it is being used and whether it can safely be stopped, changed, reduced, or taken for a shorter period.

Give your gastroenterologist a complete medication history rather than listing prescriptions alone. Include over-the-counter pain relievers and medicines prescribed by other clinicians. The FDA labeling cited for an individual NSAID contains a class-related warning that NSAIDs can cause serious gastrointestinal bleeding, ulceration, and perforation, sometimes without warning symptoms. It also identifies previous peptic ulcer disease or gastrointestinal bleeding as important risk factors and notes added risk with certain concomitant medicines. Exact labeling and individual risk vary by product and patient.

If you take aspirin for cardiovascular protection, an anticoagulant for clot prevention, or a prescribed NSAID for another condition, do not make an independent change after learning that you have an ulcer. Ask which clinician should coordinate the decision and what tradeoffs need to be considered. The plan must account for why the medicine was prescribed as well as its possible contribution to ulcer risk.

Asking directly about the likely cause can replace assumptions with a plan grounded in your history, medication exposure, and test results. The GastroDoxs overview of peptic ulcer disease symptoms and causes offers useful background to review before your appointment.

The American College of Gastroenterology recommends H. pylori testing for people with active peptic ulcer disease or a prior history of it unless eradication has already been documented. That does not mean every patient needs the same test. Symptoms, evidence of bleeding, medication history, age, risk context, previous findings, and clinical judgment can inform whether the plan includes a breath test, stool test, endoscopy, or a combination.

Upper endoscopy provides information that a breath or stool test cannot. It allows the gastroenterologist to see the stomach and duodenum directly, identify an ulcer, obtain biopsies, and use endoscopic tools to treat certain bleeding ulcers. Noninvasive testing can evaluate active H. pylori infection without a procedure. Ask what question the recommended test is intended to answer and whether any medicine or preparation could affect the result.

The GastroDoxs guide to how peptic ulcers are diagnosed and how H. pylori is tested can help you prepare. If a clinically significant acute upper gastrointestinal bleed is suspected, ASGE educational guidance states that endoscopy should generally occur within 24 hours after presentation and stabilization. That timing applies to significant acute bleeding, not to stable patients without evidence of bleeding.

Once the likely cause is established, ask your gastroenterologist to explain each part of the plan. For H. pylori infection, NIDDK describes treatment with two or more antibiotics plus a proton-pump inhibitor, with bismuth included in some regimens. The ACG's 2024 guideline identifies optimized bismuth quadruple therapy for 14 days as one option for treatment-naive infection and for some previously treated patients. It includes a PPI, bismuth, tetracycline, and metronidazole.

That example is not a universal prescription. Previous antibiotic exposure, allergies, resistance considerations, prior treatment, and other individual factors can influence the regimen. Ask why your combination was selected, how to take each component, and whom to contact if side effects or practical barriers make completion difficult. NIDDK warns that stopping early can allow infection to persist and contribute to antibiotic resistance. Contact the care team instead of abandoning treatment on your own.

For an NSAID-associated ulcer, NIDDK notes that a clinician may stop, change, lower, or shorten NSAID therapy. If continued use is necessary, a PPI may be added. The appropriate choice depends on the condition being treated and the patient's overall situation. Changes involving prescribed NSAIDs, aspirin, or anticoagulants should be coordinated with the clinician managing those medicines.

Clarify practical details before leaving: which medicine treats the infection, which reduces acid, what to do about a missed dose, and whether cost or pill burden could interfere with treatment. Do not assume a general schedule applies to you. GastroDoxs provides a broader review of peptic ulcer disease treatment options, but your instructions should come from your treating clinician.

Finishing H. pylori treatment is not the final confirmation step. ACG guidance recommends a test of cure using a urea breath test, stool antigen test, or biopsy-based test. The 2024 guideline summary specifies testing at least four weeks after antibiotics are completed. It also advises withholding PPIs for one to two weeks and withholding antibiotics and bismuth for four weeks to reduce false-negative results.

Those medication holds must be clinician-directed. Do not stop a PPI, antibiotic, bismuth product, or another prescribed medicine simply because you have read a general timeline. Ask for written preparation instructions, including the date treatment ended, which medicines should be held, and when they can be resumed. If following the instructions is difficult or unsafe for you, contact the care team before the test.

An appropriately timed and prepared negative result supports H. pylori eradication, but results still require clinical interpretation. Test timing, medication exposure, and other circumstances can affect reliability. If a result is uncertain or does not fit the clinical picture, your clinician can decide whether further assessment is needed. A positive test indicates persistent infection and prompts a discussion about another treatment approach.

Follow-up for the ulcer itself is not identical for every patient. The supplied sources do not establish one repeat-endoscopy schedule or one PPI duration for all gastric and duodenal ulcers. Ask whether the ulcer's location, biopsy findings, symptoms, medication needs, or response to therapy changes the follow-up plan. Keeping “infection eradication” and “ulcer healing” as separate questions can make the answer clearer.

• Ask when to test: ACG guidance places H. pylori test-of-cure at least four weeks after antibiotics.
• Ask which test is planned: Options include a urea breath test, stool antigen test, or biopsy-based testing.
• Request preparation instructions: PPIs, antibiotics, and bismuth can affect reliability, and any medication hold should be directed by your clinician.
• Clarify what the result means: An appropriately performed negative result supports eradication; a positive or uncertain result needs clinician interpretation and a follow-up plan.

• Contact your care team if symptoms persist or return after treatment. Persistent or recurrent ulcers may prompt evaluation for ongoing H. pylori infection, continued exposure to ulcer-causing medicines, smoking, uncommon causes, or another diagnosis.
• Ask for follow-up if you are unable to complete H. pylori therapy. Do not quietly stop the regimen or substitute medicines without guidance; the clinician needs to know what you took and for how long.
• Discuss any positive, uncertain, or potentially unreliable test-of-cure result. The timing of the test and medication preparation should be reviewed before conclusions are drawn.
• Tell your clinician about fatigue, weakness, pallor, or shortness of breath with exertion. ACG notes that slow ulcer bleeding can cause anemia, but these symptoms are nonspecific and require clinical assessment rather than automatic attribution to an ulcer.
• Schedule a medication review before starting or resuming an NSAID when you have a history of peptic ulcer disease. Bring the medicine's name, dose, reason for use, and prescriber's information.
• Ask whether repeat endoscopy or biopsies are appropriate if an ulcer does not heal or returns. NIDDK notes that additional medication, repeat upper endoscopy with biopsies, and, rarely, surgery may be considered in these circumstances.